NSE:CAMLINFINE

Camlin Fine Sciences Limited · NSE · Basic Materials · INR · FY for 2026

Figures on this page computed 2026-11-08 12:58 UTC

Last close

n/aINR

Market data

  • 52.1xP/E

    Price / Earnings per Share (diluted)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    INR
    • computed
    • Computed from the filing for 2026
  • 1.5%ROIC

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    INR
    • Computed from the filing for 2026
    • Computed from the filing for 2026
    • Computed from the filing for 2026
    • Computed from the filing for 2026
    • Computed from the filing for 2026
    • Computed from the filing for 2026
  • 1.6%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    INR
    • Computed from the filing for 2026
    • Computed from the filing for 2026
  • -1.9%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    INR
    • Computed from the filing for 2026
    • Computed from the filing for 2026
  • 0.69Debt/equity

    Total Debt / Shareholders' Equity

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    INR
    • Computed from the filing for 2026
    • Computed from the filing for 2026
  • n/aDividend yield

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    INR
    • computed

Five bars, one line

lens 7 of 9
1.39x
-5.48x
1.11x
1.24x
n/a
SalesProfitFree cash flowDebtPrice
Each bar against this company's own average; the line is that average.
Computed2026
Computed2026
Computed2026
Computed2026
Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2026

  • Sales1.39x

    Its own average over 10 years, 12.42B.

  • Profit-5.48x

    Its own average over 10 years, -50.4M.

  • Free cash flow1.11x

    Its own average over 10 years, -299.3M.

  • Debt1.24x

    Its own average over 10 years, 5.78B.

  • Pricen/a

    Its own average over 0 years. Market data

Profit is furthest from its own average, at -5.48 times.

Sales is 1.39 times its own 10-year average; Profit is -5.48 times its own 10-year average; Free cash flow is 1.11 times its own 10-year average; Debt is 1.24 times its own 10-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2026

  • Sales against its own 10-year average1.39
    Source
    computed
    Statement
    income
    Fiscal year
    2026
    Reported in
    INR
  • Profit against its own 10-year average-5.48
    Source
    computed
    Statement
    income
    Fiscal year
    2026
    Reported in
    INR
  • Free cash flow against its own 10-year average1.11
    Source
    computed
    Statement
    income
    Fiscal year
    2026
    Reported in
    INR
  • Debt against its own 10-year average1.24
    Source
    computed
    Statement
    income
    Fiscal year
    2026
    Reported in
    INR
  • Price against its own 0-year averagen/aMarket data

    Not held.

    Source
    market
    Reported in
    INR

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.